API Holdings – PharmEasy Listing Price Justified?
Pharma Industry Overview Indian pharma is a ~INR 2.1 trillion (~US$28 billion) opportunity and is projected to become ~INR 3.2 trillion (~US$43 billion) by 2025 (growing at ~9% CAGR), led…
Pharma Industry Overview Indian pharma is a ~INR 2.1 trillion (~US$28 billion) opportunity and is projected to become ~INR 3.2 trillion (~US$43 billion) by 2025 (growing at ~9% CAGR), led…
PharmEasy (API Holdings) Price Drop: Why? Share of API holdings (Pharmeasy) became available in the unlisted markets at around 100/sh around 4-5 months back. A lot of investors had invested…